Vocat A - Search Results

1

Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity.

Monakhova N, Korduláková J, Vocat A, Egorova A, Lepioshkin A, Salina EG, Nosek J, Repková E, Zemanová J, Jurdáková H, Górová R, Roh J, Degiacomi G, Sammartino JC, Pasca MR, Cole ST, Mikušová K, Makarov V. Monakhova N, et al. Among authors: vocat a. ACS Infect Dis. 2021 Jan 8;7(1):88-100. doi: 10.1021/acsinfecdis.0c00622. Epub 2020 Dec 22. ACS Infect Dis. 2021. PMID: 33352041

2

New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.

Salina EG, Ryabova O, Vocat A, Nikonenko B, Cole ST, Makarov V. Salina EG, et al. Among authors: vocat a. J Infect Chemother. 2017 Nov;23(11):794-797. doi: 10.1016/j.jiac.2017.04.012. Epub 2017 May 18. J Infect Chemother. 2017. PMID: 28527650

3

The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.

Makarov V, Neres J, Hartkoorn RC, Ryabova OB, Kazakova E, Šarkan M, Huszár S, Piton J, Kolly GS, Vocat A, Conroy TM, Mikušová K, Cole ST. Makarov V, et al. Among authors: vocat a. Antimicrob Agents Chemother. 2015 Aug;59(8):4446-52. doi: 10.1128/AAC.00778-15. Epub 2015 May 18. Antimicrob Agents Chemother. 2015. PMID: 25987616 Free PMC article.

4

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.

Karabanovich G, Zemanová J, Smutný T, Székely R, Šarkan M, Centárová I, Vocat A, Pávková I, Čonka P, Němeček J, Stolaříková J, Vejsová M, Vávrová K, Klimešová V, Hrabálek A, Pávek P, Cole ST, Mikušová K, Roh J. Karabanovich G, et al. Among authors: vocat a. J Med Chem. 2016 Mar 24;59(6):2362-80. doi: 10.1021/acs.jmedchem.5b00608. Epub 2016 Mar 15. J Med Chem. 2016. PMID: 26948407

5

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.

Piton J, Vocat A, Lupien A, Foo CS, Riabova O, Makarov V, Cole ST. Piton J, et al. Among authors: vocat a. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00681-18. doi: 10.1128/AAC.00681-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30012754 Free PMC article.

6

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).

Lupien A, Vocat A, Foo CS, Blattes E, Gillon JY, Makarov V, Cole ST. Lupien A, et al. Among authors: vocat a. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e00840-18. doi: 10.1128/AAC.00840-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30126954 Free PMC article.

7

Synthesis and Structure-Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin.

Kienle M, Eisenring P, Stoessel B, Horlacher OP, Hasler S, van Colen G, Hartkoorn RC, Vocat A, Cole ST, Altmann KH. Kienle M, et al. Among authors: vocat a. J Med Chem. 2020 Feb 13;63(3):1105-1131. doi: 10.1021/acs.jmedchem.9b01457. Epub 2020 Jan 21. J Med Chem. 2020. PMID: 31904960

8

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.

Lupien A, Foo CS, Savina S, Vocat A, Piton J, Monakhova N, Benjak A, Lamprecht DA, Steyn AJC, Pethe K, Makarov VA, Cole ST. Lupien A, et al. Among authors: vocat a. PLoS Pathog. 2020 Jan 23;16(1):e1008270. doi: 10.1371/journal.ppat.1008270. eCollection 2020 Jan. PLoS Pathog. 2020. PMID: 31971990 Free PMC article.

9

Machine Learning Models for Mycobacterium tuberculosisIn Vitro Activity: Prediction and Target Visualization.

Lane TR, Urbina F, Rank L, Gerlach J, Riabova O, Lepioshkin A, Kazakova E, Vocat A, Tkachenko V, Cole S, Makarov V, Ekins S. Lane TR, et al. Among authors: vocat a. Mol Pharm. 2022 Feb 7;19(2):674-689. doi: 10.1021/acs.molpharmaceut.1c00791. Epub 2021 Dec 29. Mol Pharm. 2022. PMID: 34964633 Free PMC article.

10

Synthesis and In Vitro Biological Evaluation of Quinolinyl Pyrimidines Targeting Type II NADH-Dehydrogenase (NDH-2).

Lu L, Åkerbladh L, Ahmad S, Konda V, Cao S, Vocat A, Maes L, Cole ST, Hughes D, Larhed M, Brandt P, Karlén A, Mowbray SL. Lu L, et al. Among authors: vocat a. ACS Infect Dis. 2022 Mar 11;8(3):482-498. doi: 10.1021/acsinfecdis.1c00413. Epub 2022 Feb 21. ACS Infect Dis. 2022. PMID: 35184552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page